Dr Hama lays out the potential benefits and cautions surrounding CRISPR gene editing, noting the challenges it still faces for use in fighting human diseases.
A Japanese research team has found a way to improve genome editing, but complex regulations hinder Japanese technology from reaching the clinical stage.
